Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1

Narendra Chaudhary, Anupama Borker

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor especially in the patients with neurofibromatosis type 1 (NF1). Without a complete surgical excision, prognosis is guarded. We describe a 10-year-old male with NF1 with MPNST, who had a local relapse within 5 weeks of surgical excision. Chemoradiotherapy did not result in tumor regression. Initiation of palliative oral metronomic therapy resulted in complete remission after six cycles. The patient continues to be in remission, 20 months after completion of nine cycles of metronomic therapy. Metronomic therapy may be effective in MPNST where conventional chemotherapy and radiotherapy fails.

Original languageEnglish
Pages (from-to)1317-1319
Number of pages3
JournalPediatric Blood and Cancer
Volume59
Issue number7
DOIs
Publication statusPublished - 15-12-2012
Externally publishedYes

Fingerprint

Neurofibromatosis 1
Neurilemmoma
Chemoradiotherapy
Neoplasms
Radiotherapy
Therapeutics
Recurrence
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Chaudhary, Narendra ; Borker, Anupama. / Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1. In: Pediatric Blood and Cancer. 2012 ; Vol. 59, No. 7. pp. 1317-1319.
@article{5b3dc3c429ef494aa0601f68a6458fa8,
title = "Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1",
abstract = "Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor especially in the patients with neurofibromatosis type 1 (NF1). Without a complete surgical excision, prognosis is guarded. We describe a 10-year-old male with NF1 with MPNST, who had a local relapse within 5 weeks of surgical excision. Chemoradiotherapy did not result in tumor regression. Initiation of palliative oral metronomic therapy resulted in complete remission after six cycles. The patient continues to be in remission, 20 months after completion of nine cycles of metronomic therapy. Metronomic therapy may be effective in MPNST where conventional chemotherapy and radiotherapy fails.",
author = "Narendra Chaudhary and Anupama Borker",
year = "2012",
month = "12",
day = "15",
doi = "10.1002/pbc.24245",
language = "English",
volume = "59",
pages = "1317--1319",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1. / Chaudhary, Narendra; Borker, Anupama.

In: Pediatric Blood and Cancer, Vol. 59, No. 7, 15.12.2012, p. 1317-1319.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1

AU - Chaudhary, Narendra

AU - Borker, Anupama

PY - 2012/12/15

Y1 - 2012/12/15

N2 - Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor especially in the patients with neurofibromatosis type 1 (NF1). Without a complete surgical excision, prognosis is guarded. We describe a 10-year-old male with NF1 with MPNST, who had a local relapse within 5 weeks of surgical excision. Chemoradiotherapy did not result in tumor regression. Initiation of palliative oral metronomic therapy resulted in complete remission after six cycles. The patient continues to be in remission, 20 months after completion of nine cycles of metronomic therapy. Metronomic therapy may be effective in MPNST where conventional chemotherapy and radiotherapy fails.

AB - Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor especially in the patients with neurofibromatosis type 1 (NF1). Without a complete surgical excision, prognosis is guarded. We describe a 10-year-old male with NF1 with MPNST, who had a local relapse within 5 weeks of surgical excision. Chemoradiotherapy did not result in tumor regression. Initiation of palliative oral metronomic therapy resulted in complete remission after six cycles. The patient continues to be in remission, 20 months after completion of nine cycles of metronomic therapy. Metronomic therapy may be effective in MPNST where conventional chemotherapy and radiotherapy fails.

UR - http://www.scopus.com/inward/record.url?scp=84867373047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867373047&partnerID=8YFLogxK

U2 - 10.1002/pbc.24245

DO - 10.1002/pbc.24245

M3 - Article

C2 - 22745048

AN - SCOPUS:84867373047

VL - 59

SP - 1317

EP - 1319

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 7

ER -